Health
Judging Success in Translational Medical Research
Getting promising drug discoveries out of university labs and into the drug pipeline is more difficult than it should be.
Getting promising drug discoveries out of university labs and into the drug pipeline is more difficult than it should be.
NGOs, social entrepreneurs, impact investors, and philanthropists need to help slow climate warming.
The views of those who benefit from social programs offer insight into a program’s effectiveness.
Part of a special series on scaling mobile health initiatives.
A review of the upcoming film “The Impossible” through the eyes of a disaster recovery philanthropist.
Armed with robust shared measurement systems, national nonprofit networks are well positioned to scale promising and proven programs.
The New England Compounding Center meningitis case spotlights the tragic consequences of failed organizational ethics.
Eric Dishman, director of health innovation at Intel, asserts that mobile technologies can create sustainable healthcare for all.
When it comes to expanding medical supply chains in the developing world, there is much to be learned from Coca-Cola’s global-scale production and distribution model.